GXV-001

N/A

Report date: 2024/01/12 14:49:10
NME

Base Information

Drug NameGXV-001
Drug Alias NameGXV-001
ClassificationOther
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAutistic DisorderAttention Deficit Disorder with HyperactivityBipolar Disorder +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGEXVal Inc
Inactive CompaniesN/A
Active IndicationsAutistic DisorderAttention Deficit Disorder with HyperactivityBipolar Disorder +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A